Bodil Als‐Nielsen

5.9k total citations · 4 hit papers
55 papers, 4.1k citations indexed

About

Bodil Als‐Nielsen is a scholar working on Public Health, Environmental and Occupational Health, Hepatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Bodil Als‐Nielsen has authored 55 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 17 papers in Hepatology and 16 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Bodil Als‐Nielsen's work include Liver Disease and Transplantation (17 papers), Acute Lymphoblastic Leukemia research (16 papers) and Childhood Cancer Survivors' Quality of Life (11 papers). Bodil Als‐Nielsen is often cited by papers focused on Liver Disease and Transplantation (17 papers), Acute Lymphoblastic Leukemia research (16 papers) and Childhood Cancer Survivors' Quality of Life (11 papers). Bodil Als‐Nielsen collaborates with scholars based in Denmark, Sweden and United States. Bodil Als‐Nielsen's co-authors include Christian Gluud, Lise Lotte Gluud, Lise Lotte Kjaergard, Wendong Chen, John P. A. Ioannidis, Jianping Liu, Hayley E Jones, Jonathan A C Sterne, Peter Jüni and David Moher and has published in prestigious journals such as JAMA, Annals of Internal Medicine and Cochrane Database of Systematic Reviews.

In The Last Decade

Bodil Als‐Nielsen

47 papers receiving 4.0k citations

Hit Papers

4 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials

2012 768 citations Bodil Als‐Nielsen, Christian Gluud et al. profile →
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?

2008 625 citations Lise Lotte Gluud, Bodil Als‐Nielsen et al. profile →
Association of Funding and Conclusions in Randomized Drug Trials

2003 526 citations Bodil Als‐Nielsen, Wendong Chen et al. JAMA profile →
Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.

2012 519 citations Bodil Als‐Nielsen, Christian Gluud et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bodil Als‐Nielsen Denmark	22	1.2k	1.1k	1.0k	602	526	55	4.1k
Lise Lotte Kjaergard Denmark	14	602 0.5×	531 0.5×	697 0.7×	673 1.1×	689 1.3×	22	3.1k
Jesper Brok Denmark	31	1.2k 1.0×	1.8k 1.6×	1.4k 1.4×	295 0.5×	293 0.6×	86	6.7k
Alison Jones United States	6	324 0.3×	533 0.5×	653 0.6×	992 1.6×	115 0.2×	7	3.7k
M Moher United Kingdom	11	320 0.3×	557 0.5×	633 0.6×	799 1.3×	94 0.2×	13	3.5k
Julie Pildal Denmark	9	280 0.2×	434 0.4×	324 0.3×	526 0.9×	84 0.2×	13	2.0k
Eswar Krishnan United States	50	313 0.3×	1.0k 0.9×	1.7k 1.7×	49 0.1×	145 0.3×	113	7.5k
Patricia W. Spitz United States	20	266 0.2×	497 0.4×	1.0k 1.0×	79 0.1×	140 0.3×	25	8.1k
Christian Mallen United Kingdom	48	257 0.2×	976 0.9×	1.7k 1.7×	43 0.1×	99 0.2×	423	8.8k
Joshua J. Ofman United States	37	203 0.2×	794 0.7×	2.6k 2.5×	61 0.1×	109 0.2×	94	5.4k
Jean Jacques Noubiap Cameroon	38	396 0.3×	1.4k 1.3×	447 0.4×	32 0.1×	53 0.1×	244	5.3k

Countries citing papers authored by Bodil Als‐Nielsen

Since Specialization

Citations

This map shows the geographic impact of Bodil Als‐Nielsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bodil Als‐Nielsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bodil Als‐Nielsen more than expected).

Fields of papers citing papers by Bodil Als‐Nielsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bodil Als‐Nielsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bodil Als‐Nielsen. The network helps show where Bodil Als‐Nielsen may publish in the future.

Co-authorship network of co-authors of Bodil Als‐Nielsen

This figure shows the co-authorship network connecting the top 25 collaborators of Bodil Als‐Nielsen. A scholar is included among the top collaborators of Bodil Als‐Nielsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bodil Als‐Nielsen. Bodil Als‐Nielsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thastrup, Ole, Hanne Vibeke Marquart, Mette Levinsen, et al.. (2025). Flow cytometric analysis of cerebrospinal fluid identifies patients with occult central nervous system involvement in relapsed pediatric acute lymphoblastic leukemia. Haematologica. 111(1). 355–360.

Sluis, Inge M. van der, Erica Brivio, Raheel Altaf Raja, et al.. (2025). Therapeutic drug monitoring in acute lymphoblastic leukemia–a deep dive into pharmacokinetics, -dynamics, and -genetics of antileukemic drugs. Expert Review of Clinical Pharmacology. 18(3). 131–149. 1 indexed citations

Als‐Nielsen, Bodil, Ximo Duarte, Gabriele Escherich, et al.. (2025). DNA-incorporated thioguanine to detect potential non-adherence to maintenance therapy in acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 95(1). 76–76.

Pietri, Silvia De, Claus Henrik Nielsen, Mathias Rathe, et al.. (2024). Upregulation of Insulin-like Growth Factor-I in Response to Chemotherapy in Children with Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 25(17). 9582–9582.

Rathe, Mathias, Allan Weimann, Christian Enevold, et al.. (2023). Markers of intestinal mucositis to predict blood stream infections at the onset of fever during treatment for childhood acute leukemia. Leukemia. 38(1). 14–20. 4 indexed citations

Thomsen, Birthe Lykke, Bodil Als‐Nielsen, Rachel Conyers, et al.. (2023). Physician-defined severe toxicities occurring during and after cancer treatment: Modified consensus definitions and clinical applicability in the evaluation of cancer treatment. Frontiers in Pediatrics. 11. 1155449–1155449.

Mølgaard, Christian, et al.. (2023). Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: A systematic review and meta‐analysis. Pediatric Blood & Cancer. 70(12). e30683–e30683. 2 indexed citations

Rank, Cecilie Utke, et al.. (2023). PEG-asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta-analysis. Cochrane Database of Systematic Reviews. 2023(5). CD014570–CD014570. 1 indexed citations

Nersting, Jacob, Ruta Tuckuviene, Peder Skov Wehner, et al.. (2021). Socioeconomic position and maintenance therapy in children with acute lymphoblastic leukemia: A national cohort study. Pediatric Blood & Cancer. 69(7). e29508–e29508. 5 indexed citations

10.

Hjalgrim, Lisa Lyngsie, Kathrine Grell, Kim Kristensen, et al.. (2020). Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 86(1). 25–32. 11 indexed citations

11.

Rank, Cecilie Utke, Nina Toft, Ove Juul Nielsen, et al.. (2019). Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia. Cochrane Database of Systematic Reviews. 6 indexed citations

12.

Junker, Anders, Bodil Als‐Nielsen, Christian Gluud, & Lise Lotte Gluud. (2014). Dopamine agents for hepatic encephalopathy. Cochrane Database of Systematic Reviews. 2014(2). CD003047–CD003047. 22 indexed citations

13.

Hilden, Jørgen, Inga Lind, Hans Jørn Kolmos, et al.. (2010). Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial. Diagnostic Microbiology and Infectious Disease. 66(4). 385–392. 10 indexed citations

14.

Gluud, Christian, Bodil Als‐Nielsen, Morten Damgaard, et al.. (2008). Clarithromycin for 2 Weeks for Stable Coronary Heart Disease: 6-Year Follow-Up of the CLARICOR Randomized Trial and Updated Meta-Analysis of Antibiotics for Coronary Heart Disease. Cardiology. 111(4). 280–287. 46 indexed citations

15.

Als‐Nielsen, Bodil, Lise Lotte Gluud, & Christian Gluud. (2004). Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ. 328(7447). 1046–1046. 228 indexed citations

16.

Als‐Nielsen, Bodil, Lise Lotte Gluud, & Christian Gluud. (2004). Nonabsorbable disaccharides for hepatic encephalopathy. Cochrane Database of Systematic Reviews. CD003044–CD003044. 79 indexed citations

17.

Als‐Nielsen, Bodil, Wendong Chen, Christian Gluud, & Lise Lotte Gluud. (2004). [Are treatment effects or adverse effects of significance for the association between financing and conclusions in randomized trials?].. PubMed. 166(18). 1676–8. 5 indexed citations

18.

Liu, Jianping, Lise Lotte Gluud, Bodil Als‐Nielsen, & Christian Gluud. (2004). Artificial and bioartificial support systems for liver failure. Cochrane Database of Systematic Reviews. 2009(1). CD003628–CD003628. 76 indexed citations

19.

Kjaergard, Lise Lotte, Jianping Liu, Bodil Als‐Nielsen, & Christian Gluud. (2003). Artificial and Bioartificial Support Systems for Acute and Acute-on-Chronic Liver Failure. JAMA. 289(2). 217–217. 257 indexed citations

20.

Als‐Nielsen, Bodil, Ronald L. Koretz, Lise Lotte Kjaergard, & Christian Gluud. (2001). A systematic review on branched-chain amino acids for hepatic encephalopathy. Journal of Hepatology. 34. 62–62. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact